Status:
COMPLETED
Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study
Lead Sponsor:
Essenlix Corporation
Conditions:
Hematologic Tests
Eligibility:
All Genders
18+ years
Brief Summary
This is a method comparison study for an in vitro diagnostic device. The device is a point of care automated hematology analyzer which measures CBC parameters with a small drop of venous or capillary,...
Detailed Description
These studies demonstrate that the iMOST X-1 system yields equivalent results to the Horiba predicate system when using either capillary and venous blood specimens. Furthermore, there are three altern...
Eligibility Criteria
Inclusion
- all clinic attendees
Exclusion
- unable to provide a venous and fingerstick blood specimen
Key Trial Info
Start Date :
October 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 21 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04778553
Start Date
October 19 2020
End Date
January 21 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunterdon Medical Center
Flemington, New Jersey, United States, 08822